Therapeutic Drug Monitoring in Tuberculosis: Practical Application for Physicians
Author(s) -
JanWillem C. Alffenaar,
Simon Tiberi,
Roger K. Verbeeck,
Scott K. Heysell,
Martin P. Grobusch
Publication year - 2016
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciw677
Subject(s) - medicine , tuberculosis , therapeutic drug monitoring , intensive care medicine , drug , medline , medical physics , pharmacology , pathology , political science , law
TO THE EDITOR—We studied with great interest the novel treatment guidelines for drug-susceptible tuberculosis [1]. The authors mention situations where therapeutic drug monitoring (TDM) may be useful: drug malabsorption, drug underdosing, and drug–drug interactions. Limited availability in low-resource settings, sample stability, and costs meant that TDM was not advocated for drugsusceptible tuberculosis [2] but endorsed
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom